Acute ischemic stroke and abnormal blood hemoglobin concentration

Acta Neurologica Scandinavica

Volumn 134, Issue 2, 2016, Pages 123-130

  Furlan, J C ^a,b   Fang, J ^c   Silver, F L ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO REHABILITATION INSTITUTE   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

anemia; blood hemoglobin concentration; disability; impairment; mortality; polycythemia; stroke

Indexed keywords

HEMOGLOBIN;

AGED; ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; DISABILITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; RANKIN SCALE; RETROSPECTIVE STUDY;

EID: 84978655789     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12521     Document Type: Article

References (21)

1. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009;8:355–69.
2. Kapral MK, Hall R, Stamplecoski M et al. Registry of the Canadian Stroke Network – Report on the 2008/09 Ontario Stroke Audit. Toronto: Institute for Clinical Evaluative Sciences, 2011.
3. Tsai CF, Yip PK, Chen CC, Yeh SJ, Chung ST, Jeng JS. Cerebral infarction in acute anemia. J Neurol 2010;257:2044–51.
4. Chang YL, Hung SH, Ling W, Lin HC, Li HC, Chung SD. Association between ischemic stroke and iron-deficiency anemia: a population-based study. PLoS One 2013;8:e82952.
5. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the apolipoprotein mortality risk study (AMORIS). Ann Med 2012;44:476–86.
6. Silver FL, Kapral MK, Lindsay MP, Tu JV, Richards JA. International experience in stroke registries: lessons learned in establishing the Registry of the Canadian Stroke Network. Am J Prev Med 2006;31:S235–7.
7. Bushnell CD, Johnston DC, Goldstein LB. Retrospective assessment of initial stroke severity: comparison of the NIH Stroke Scale and the Canadian Neurological Scale. Stroke 2001;32:656–60.
8. Cote R, Hachinski VC, Shurvell BL, Norris JW, Wolfson C. The Canadian Neurological Scale: a preliminary study in acute stroke. Stroke 1986;17:731–7.
9. Cote R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V. The Canadian Neurological Scale: validation and reliability assessment. Neurology 1989;39:638–43.
10. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521–6.
11. Gagnon DR, Zhang TJ, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease–the Framingham study: a 34-year follow-up. Am Heart J 1994;127:674–82.
12. Huang WY, Chen IC, Meng L, Weng WC, Peng TI. The influence of anemia on clinical presentation and outcome of patients with first-ever atherosclerosis-related ischemic stroke. J Clin Neurosci 2009;16:645–9.
13. Del Fabbro P, Luthi JC, Carrera E, Michel P, Burnier M, Burnand B. Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: a historic cohort study. BMC Nephrol 2010;11:27.
14. Tanne D, Molshatzki N, Merzeliak O, Tsabari R, Toashi M, Schwammenthal Y. Anemia status, hemoglobin concentration and outcome after acute stroke: a cohort study. BMC Neurol 2010;10:22.
15. Kellert L, Martin E, Sykora M et al. Cerebral oxygen transport failure?: decreasing hemoglobin and hematocrit levels after ischemic stroke predict poor outcome and mortality: STroke: RelevAnt Impact of hemoGlobin, Hematocrit and Transfusion (STRAIGHT) – an observational study. Stroke 2011;42:2832–37.
16. Sico JJ, Concato J, Wells CK et al. Anemia is associated with poor outcomes in patients with less severe ischemic stroke. J Stroke Cerebrovasc Dis 2013;22:271–8.
17. Gottesman RF, Bahrainwala Z, Wityk RJ, Hillis AE. Neglect is more common and severe at extreme hemoglobin levels in right hemispheric stroke. Stroke 2010;41:1641–5.
18. Kellert L, Schrader F, Ringleb P, Steiner T, Bosel J. The impact of low hemoglobin levels and transfusion on critical care patients with severe ischemic stroke: STroke: RelevAnt Impact of HemoGlobin, Hematocrit and Transfusion (STRAIGHT)–an observational study. J Crit Care 2014;29:236–40.
19. Locatelli F, Aljama P, Canaud B et al. Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study. Nephrol Dial Transplant 2010;25:2846–50.
20. Allport LE, Parsons MW, Butcher KS et al. Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke. Neurology 2005;65:1382–7.
21. Hensley B, Geyer H, Mesa R. Polycythemia vera: current pharmacotherapy and future directions. Expert Opin Pharmacother 2013;14:609–17.